![Simon Read](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Read
Directeur Technique/Scientifique/R&D chez
RA PHARMACEUTICALS, INC.
Fortune : - $ au 31/05/2026
Profil
Dr. Simon Read is an Independent Director at Dianthus Therapeutics, Inc., a Scientific Advisory Board Member at Q32 Bio Operations, Inc., a Chief Scientific Officer at RA Pharmaceuticals, Inc., a Member at The Medical Research Council and an Advisor at Atlas Venture Advisors, Inc. He is on the Board of Directors at Dianthus Therapeutics, Inc. Dr. Read was previously employed as a President, Chief Executive Officer & Director by Mariana Oncology, Inc., a VP & Head-Innovative Medicines Unit by Grünenthal GmbH, a Director-Experimental Medicine by Genentech, Inc., and an Associate Director Disease by AstraZeneca LP.
He also served on the board at TRIANA Biomedicines, Inc. He received his undergraduate degree from The University of Manchester, a graduate degree from The University of Southampton and a doctorate degree from the University of Hertfordshire.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Simon Read
| Sociétés | Poste | Début |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 04/04/2016 |
| DIANTHUS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/05/2025 |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services Provides human healthcare and social services | Corporate Officer/Principal | 01/01/2012 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Consultant / Advisor | 01/01/2021 |
Anciens postes connus de Simon Read
| Sociétés | Poste | Fin |
|---|---|---|
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Fondateur | 01/02/2024 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Manufactures medicines for pain management and related diseases | Corporate Officer/Principal | 01/01/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2011 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Private Equity Investor | 02/01/2008 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Simon Read
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services Provides human healthcare and social services | Commercial Services |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Manufactures medicines for pain management and related diseases | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hertfordshire
 University of Hertfordshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Santi Therapeutics, Inc.
Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Health Technology |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
